XML 45 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating Expenses [Abstract]    
Research and development $ 68,126 $ 54,077
General and administrative 16,640 14,224
Total operating expenses 84,766 68,301
Operating loss (84,766) (68,301)
Other income (expense)    
Interest income 6,400 2,793
Other income (expense), net (187) 110
Total other income, net 6,213 2,903
Net loss before income tax (78,553) (65,398)
Income tax expense (73) (3,706)
Net loss $ (78,626) $ (69,104)
Net loss per share, basic $ (3.3) $ (4.42)
Net loss per share, diluted $ (3.3) $ (4.42)
Weighted-average common shares outstanding, basic 23,796,000 15,639,728
Weighted-average common shares outstanding, diluted 23,796,000 15,639,728